Healthcare · Drug Manufacturers Specialty Generic · NASDAQ
ANI Pharmaceuticals, Inc. (ANIP) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.78B, a trailing price-to-earnings ratio of 9.1 and a free-cash-flow yield of 9.1%. Over the most recent reported fiscal year, revenue grew 43.8% and free cash flow per share grew 191.8%.